Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Current Behavioral Neuroscience Reports
Erschienen in:

10.06.2024

The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews

verfasst von: Razi Kitaneh, Laya Jalilian-Khave, Binah Baht Ysrayl, Anna Borelli, Melissa C. Funaro, Marc N. Potenza, Gustavo A. Angarita

Erschienen in: Current Behavioral Neuroscience Reports | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review explores the role of vitamin D in the pathophysiology and management of attention-deficit/hyperactivity disorder (ADHD). Given the localization of Vitamin D receptors in brain regions implicated in ADHD and vitamin D's role in neurotransmitter regulation, this review synthesizes research that examines vitamin D's relationship to the development and therapeutic outcomes of ADHD.

Recent Findings

A systematic literature search resulted in the selection of seven reviews meeting the inclusion criteria. These reviews summarize original studies that are focused on: 1. The association between prenatal Vitamin D levels and ADHD in offspring, with meta-analyses suggesting that higher maternal serum Vitamin D levels reduce the likelihood and severity of ADHD symptoms in children. 2. Comparative analyses of Vitamin D levels in children with ADHD versus those without, showing lower Vitamin D levels in affected children. 3. Intervention studies where Vitamin D supplementation was linked to improvements in ADHD symptoms.

Results

Seven reviews met the inclusion criteria, from which the main results were: 1. Meta-analyses suggested a decreased risk of offspring with ADHD and fewer or less severe ADHD-related features later in life with higher maternal serum Vitamin D levels. 2. Children with ADHD were found to have lower serum Vitamin D levels than children without ADHD across the original literature. 3. Vitamin D supplementation was associated with improvements in ADHD symptoms.

Summary

The literature supports relationships between Vitamin D levels and ADHD, both in its emergence and clinical management. Despite these findings, further research is indicated. There remains a need for additional well-powered randomized clinical trials to provide evidence and guide clinical practice regarding the use of Vitamin D in ADHD and to ensure that interventions are efficacious, well tolerated and tailored to individual patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Diagnostic and statistical manual of mental disorders : DSM-5. 5th ed. ed. Arlington, VA: American Psychiatric Association; 2013.
2.
Sibley MH, Swanson JM, Arnold LE, Hechtman LT, Owens EB, Stehli A, et al. Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity. J Child Psychol Psychiatry. 2017;58(6):655–62.PubMedCrossRef
3.
Uchida M, Spencer TJ, Faraone SV, Biederman J. Adult Outcome of ADHD: An Overview of Results From the MGH Longitudinal Family Studies of Pediatrically and Psychiatrically Referred Youth With and Without ADHD of Both Sexes. J Atten Disord. 2018;22(6):523–34.PubMedCrossRef
4.
5.
Ginapp CA-O, Greenberg NA-O, MacDonald-Gagnon G, Angarita GA, Bold KW, Potenza MN. “Dysregulated not deficit”: a qualitative study on symptomatology of ADHD in young adults. PloS one. 2023;18(10):e0292721.PubMedPubMedCentralCrossRef
6.
Ginapp CM, Macdonald-Gagnon G, Angarita GA, Bold KW, Potenza MN. The lived experiences of adults with attention-deficit/hyperactivity disorder: A rapid review of qualitative evidence. Front Psych. 2022;13:949321.CrossRef
7.
Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP. Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. Prim Care Companion for CNS Disord. 2014;16(3):PCC.13r01600.
8.
Halmøy A, Fasmer Ob Fau - Gillberg C, Gillberg C Fau - Haavik J, Haavik J. Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord. 2009;13(2):175–87.
9.
Bélanger SA, Andrews D, Gray C, Korczak D. ADHD in children and youth: Part 1-Etiology, diagnosis, and comorbidity. Paediatr Child Health. 2018;23(7):447–53.PubMedPubMedCentralCrossRef
10.
Blackman GL, Ostrander R Fau - Herman KC, Herman KC. Children with ADHD and depression: a multisource, multimethod assessment of clinical, social, and academic functioning. J Atten Disord. 2005;8(4):195–207.
11.
Coccaro EF, Lee R Fau - McCloskey MS, McCloskey MS. Relationship between psychopathy, aggression, anger, impulsivity, and intermittent explosive disorder. Aggress Behav. 2014;14(6):526–36.
12.
Gnanavel S, Sharma P, Kaushal P, Hussain S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019;7(17):2420–6.PubMedPubMedCentralCrossRef
13.
Mayes SD, Calhoun Sl Fau - Crowell EW, Crowell EW. Learning disabilities and ADHD: overlapping spectrumn disorders. J Learn Disabil. 2000;33(5):417–24.
14.
van Emmerik-van Oortmerssen K, van de Glind G Fau - van den Brink W, van den Brink W Fau - Smit F, Smit F Fau - Crunelle CL, Crunelle Cl Fau - Swets M, Swets M Fau - Schoevers RA, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1–2):11–9.
15.
16.
Fletcher J, Wolfe B. Long-term consequences of childhood ADHD on criminal activities. J Ment Health Policy Econ. 2009;12(3):119–38.PubMedPubMedCentral
17.
18.
Matza LS, Paramore C Fau - Prasad M, Prasad M. A review of the economic burden of ADHD. Cost Eff Resour Allocation. 2005;C/E(3):5.
19.
Schein J, Adler LA, Childress A, Cloutier M, Gagnon-Sanschagrin P, Davidson M, et al. Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. J Med Econ. 2022;25(1):193–205.PubMedCrossRef
20.
Rucklidge JJ, Frampton Cm Fau - Gorman B, Gorman B Fau - Boggis A, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial. British J Psychiatry. 2014;204:306–15.
21.
Swanson JM, Kinsbourne M Fau - Nigg J, Nigg J Fau - Lanphear B, Lanphear B Fau - Stefanatos GA, Stefanatos Ga Fau - Volkow N, Volkow N Fau - Taylor E, et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev. 2017;17(1):39–59.
22.
Brookes K, Xu X Fau - Chen W, Chen W Fau - Zhou K, Zhou K Fau - Neale B, Neale B Fau - Lowe N, Lowe N Fau - Anney R, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006;11(10):934–53.
23.
Rubia K. Cognitive neuroscience of attention deficit hyperactivity disorder (ADHD) and its clinical translation. Front Hum Neurosci. 2018;12:100.PubMedPubMedCentralCrossRef
24.
Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. JAMA. 2016;315(18):1997–2008.PubMedCrossRef
25.
Goode AP, Coeytaux RR, Maslow GR, Davis N, Hill S, Namdari B, LaPointe NMA, Befus D, Lallinger KR, Bowen SE, Kosinski A, McBroom AJ, Sanders GD, Kemper AR. Nonpharmacologic treatments for attention-deficit/hyperactivity disorder: a systematic review. Pediatrics. 2018;141(6):e20180094. https://​doi.​org/​10.​1542/​peds.​2018-0094.
26.
Elliott J, Johnston A, Husereau D, Kelly SE, Eagles C, Charach A, et al. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: a systematic review and network meta-analysis. PLoS ONE. 2020;15(10):e0240584.PubMedPubMedCentralCrossRef
27.
Wilens TE, Faraone Sv Fau - Biederman J, Biederman J Fau - Gunawardene S, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111(1):179–85.
28.
Young S, Myanthi AJ. Practitioner Review: Non-pharmacological treatments for ADHD: A lifespan approach. J Child Psychol Psychiatry. 2010;51(2):116–33.PubMedCrossRef
29.
Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ. 2015;351:h5203.PubMedPubMedCentralCrossRef
30.
Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, et al. Blood Pressure Changes Associated With Medication Treatment of Adults With Attention-Deficit/Hyperactivity Disorder. J Clin Psychiatry. 2005;66(2):253–9.PubMedCrossRef
31.
Graham J, Coghill D. Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management. CNS Drugs. 2008;22(3):213–37.PubMedCrossRef
32.
Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31.PubMedCrossRef
33.
Gan J, Galer P, Ma D, Chen C, Xiong T. The effect of vitamin D supplementation on attention-deficit/hyperactivity disorder: a systematic review and meta-analysis of randomized controlled trials. J Child Adolesc Psychopharmacol. 2019;29(9):670–87.PubMedCrossRef
34.
Rosi E, Grazioli SA-O, Villa FM, Mauri M, Gazzola E, Pozzi M, et al. Use of non-pharmacological supplementations in children and adolescents with attention deficit/hyperactivity disorder: a critical review. Nutrients. 2020;12(6):1573.PubMedPubMedCentralCrossRef
35.
Ellison-Wright I, Ellison-Wright Z, Bullmore E. Structural brain change in attention deficit hyperactivity disorder identified by meta-analysis. BMC Psychiatry. 2008;8(1):51.PubMedPubMedCentralCrossRef
36.
Ye X, Zhou Q, Ren P, Xiang W, Xiao L. The synaptic and circuit functions of vitamin D in neurodevelopment disorders. Neuropsychiatr Dis Treat. 2023;19:1515–30.PubMedPubMedCentralCrossRef
37.
Eyles DW, Smith S Fau - Kinobe R, Kinobe R Fau - Hewison M, Hewison M Fau - McGrath JJ, McGrath JJ. Distribution of the Vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21–30.
38.
Trinko JA-O, Land BB, Solecki WA-O, Wickham RJ, Tellez LA-O, Maldonado-Aviles J, et al. Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption. eNeuro. 2016;3(2):ENEURO.0122–15.2016.
39.
Cui X, Pertile R, Liu P, Eyles DW. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90–100.PubMedCrossRef
40.
Eyles DW, Feron F Fau - Cui X, Cui X Fau - Kesby JP, Kesby Jp Fau - Harms LH, Harms Lh Fau - Ko P, Ko P Fau - McGrath JJ, et al. Developmental Vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009;34:S247–S57.
41.
Kaneko I, Sabir MS, Dussik CM, Whitfield GK, Karrys A, Hsieh JC, et al. 1,25-DihydroxyVitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of Vitamin D. FASEB J. 2015;29(9):4023–35.PubMedCrossRef
42.
Pertile RA, Cui X, Eyles DW. Vitamin D signaling and the differentiation of developing dopamine systems. Neuroscience. 2016;333:193–203.PubMedCrossRef
43.
García-Serna AM, Morales E. Neurodevelopmental effects of prenatal Vitamin D in humans: systematic review and meta-analysis. Int J Mol Sci. 2020;25(10):2468–81.
44.
Morales E, Julvez J Fau - Torrent M, Torrent M Fau - Ballester F, Ballester F Fau - Rodríguez-Bernal CL, Rodríguez-Bernal Cl Fau - Andiarena A, Andiarena A Fau - Vegas O, et al. Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood. Epidemiology (Cambridge, Mass). 2015;26(4):458–65.
45.
Mossin MH, Aaby JB, Dalgård C, Lykkedegn S, Christesen HT, Bilenberg N. Inverse associations between cord Vitamin D and attention deficit hyperactivity disorder symptoms: A child cohort study. Aust N Z J Psychiatry. 2017;51(7):703–10.PubMedCrossRef
46.
Ma SS, Zhu DM, Yin WJ, Hao JH, Huang K, Tao FB, et al. The role of neonatal Vitamin D in the association of prenatal depression with toddlers ADHD symptoms: a birth cohort study. J Affect Disord. 2021;281:390–6.PubMedCrossRef
47.
Gustafsson P, Rylander L, Lindh CH, Jönsson BA, Ode A, Olofsson P, et al. Vitamin D status at birth and future risk of attention deficit/hyperactivity disorder (ADHD). PLoS ONE. 2015;10(10):e0140164.PubMedPubMedCentralCrossRef
48.
Bener A, Kamal M. Predict attention deficit hyperactivity disorder? Evidence -based medicine. Global J Health Sci. 2013;6(2):47–57.CrossRef
49.
50.
Mohammadzadeh Honarvar N, Samadi M, Seyedi Chimeh M, Gholami F, Bahrampour N, Jalali M, Effatpanah M, Yekaninejad MS, Abdolahi M, Chamari M. Effect of Vitamin D on paraxonase-1, total antioxidant capacity, and 8-isoprostan in children with attention deficit hyperactivity disorder. Int J Clin Pract. 2022;2022:4836731. https://​doi.​org/​10.​1155/​2022/​4836731.
51.
Naeini AA, Fasihi F, Najafi M, Ghazvini MR, Hasanzadeh A. The effects of Vitamin D supplementation on ADHD (attention deficit hyperactivity disorder) in 6–13 year-old students: a randomized, double-blind, placebo-controlled study. Eur J Integr Med. 2019;25:28–33.CrossRef
52.
Dehbokri N, Noorazar G, Ghaffari A, Mehdizadeh G, Sarbakhsh P, Ghaffary S. Effect of Vitamin D treatment in children with attention-deficit hyperactivity disorder. World J Pediatr : WJP. 2019;15(1):78–84.PubMedCrossRef
53.
Elshorbagy HH, Barseem NF, Abdelghani WE, Suliman HAI, Al-Shokary AH, Abdulsamea SE, et al. Impact of Vitamin D supplementation on attention-deficit hyperactivity disorder in children. Ann Pharmacother. 2018;52(7):623–31.PubMedCrossRef
54.
Mohammadpour N, Jazayeri S, Tehrani-Doost M, Djalali M, Hosseini M, Effatpanah M, Davari-Ashtiani R, Karami E. Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: a randomized, double blind, placebo-controlled trial. Nutr Neurosci. 2018;21(3):202–09. https://​doi.​org/​10.​1080/​1028415X.​2016.​1262097.
55.
56.
Jalilian-Khave L, Potenza MN, Angarita GA, Kitaneh R, Funaro MC, Ysrayl BB. An overview of a review protocol for Vitamin D and the development and treatment of attention-deficit hyperactivity disorder  [Internet]. OSF; 2023. Available from: osf.​io/​qzn8t
57.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.PubMedCrossRef
58.
Association AP. Diagnostic and statistical manual of mental disorders (3rd ed.). 1980.
59.
Association AP. Diagnostic and statistical manual of mental disorders (3rd ed., rev.). 1987.
60.
Association AP. Diagnostic and statistical manual of mental disorders (4th ed.). 1994.
61.
Association AP. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). 2000.
62.
Association AP. Diagnostic and statistical manual of mental disorders (5th ed.) 2013.
63.
Association AP. Diagnostic and statistical manual of mental disorders (5th ed., text rev.) 2022.
64.
(WHO) WHO. The ICD-10 classification of mental and behavioural disorders: World Health Organization; 1993.
65.
(WHO) WHO. The ICD-9 classification of mental and behavioural disorders: World Health Organization; 1997.
66.
Khoshbakht Y, Bidaki R, Salehi-Abargouei A. Vitamin D status and attention deficit hyperactivity disorder: a systematic review and meta-analysis of observational studies. Adv Nutr. 2018;9(1):9–20.PubMedPubMedCentralCrossRef
67.
Föcker M, Antel J, Ring S, Hahn D, Kanal Ö, Öztürk D, et al. Vitamin D and mental health in children and adolescents. Eur Child Adolesc Psychiatry. 2017;26(9):1043–66.PubMedCrossRef
68.
Kotsi E, Kotsi E, Perrea DN. Vitamin D levels in children and adolescents with attention-deficit hyperactivity disorder (ADHD): a meta-analysis. Atten Defic Hyperact Disord. 2019;11(3):221–32.PubMedCrossRef
69.
Tirani SA, Balali A, Askari G, Saneei P. Maternal serum 25-hydroxy Vitamin D levels and risk of autism spectrum and attention-deficit hyperactivity disorders in offspring: a systematic review and dose-response meta-analysis. Psychiatry Res. 2023;319:114977.PubMedCrossRef
70.
71.
Chu SH, Huang M, Kelly RS, Kachroo P, Litonjua AA, Weiss ST, Lasky-Su J. Circulating levels of maternal Vitamin D and risk of ADHD in offspring: results from the Vitamin D Antenatal Asthma Reduction Trial. Int J Epidemiol. 2022;51(3):910–8.PubMedCrossRef
72.
Sucksdorff M, Brown AS, Chudal R, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, et al. Maternal Vitamin D levels and the risk of offspring attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2021;60(1):142-51.e2.PubMedCrossRef
73.
Daraki V, Roumeliotaki T, Koutra K, Chalkiadaki G, Katrinaki M, Kyriklaki A, et al. High maternal Vitamin D levels in early pregnancy may protect against behavioral difficulties at preschool age: the Rhea mother-child cohort, Crete. Greece Eur Child Adolesc Psychiatry. 2018;27(1):79–88.PubMedCrossRef
74.
Morales E, Julvez J, Torrent M, Ballester F, Rodríguez-Bernal CL, Andiarena A, et al. Vitamin D in pregnancy and attention deficit hyperactivity disorder-like symptoms in childhood. Epidemiology. 2015;26(4):458–65.PubMedCrossRef
75.
Strøm M, Halldorsson TI, Hansen S, Granström C, Maslova E, Petersen SB, et al. Vitamin D measured in maternal serum and offspring neurodevelopmental outcomes: a prospective study with long-term follow-up. Ann Nutr Metab. 2014;64(3–4):254–61.PubMedCrossRef
76.
García-Serna AM, Morales E. Neurodevelopmental effects of prenatal Vitamin D in humans: systematic review and meta-analysis. Mol Psychiatry. 2020;25(10):2468–81.PubMedCrossRef
77.
Sharif MR, Madani M, Tabatabaei F, Tabatabaee Z. The relationship between Serum Vitamin D level and attention deficit hyperactivity disorder. Iran J Child Neurol. 2015;9(4):48–53.PubMedPubMedCentral
78.
Shang-Guan LL, Zhao YR. Serum levels of 25-hydroxyVitamin D in children with attention deficit hyperactivity disorder. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17(8):837–40.PubMed
79.
Goksugur SB, Tufan AE, Semiz M, Gunes C, Bekdas M, Tosun M, Demircioglu F. Vitamin D status in children with attention-deficit-hyperactivity disorder. Pediatr Int. 2014;56(4):515–9.PubMedCrossRef
80.
81.
Meyer T, Becker A, Sundermann J, Rothenberger A, Herrmann-Lingen C. Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum Vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Eur Child Adolesc Psychiatry. 2017;26(2):165–75.PubMedCrossRef
82.
Bala KA, Doğan M, Kaba S, Mutluer T, Aslan O, Doğan SZ. Hormone disorder and Vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs). J Pediatr Endocrinol Metab. 2016;29(9):1077–82.PubMedCrossRef
83.
Avcil S, Uysal P, Yilmaz M, Erge D, Demirkaya SK, Eren E. Vitamin D deficiency and a blunted parathyroid hormone response in children with attention-deficit/hyperactivity disorder. Clin Lab. 2017;63(3):435–43.PubMed
84.
Garipardic M, Doğan M, Bala KA, Mutluer T, Kaba S, Aslan O, Üstyol L. Association of attention deficit hyperactivity disorder and autism spectrum disorders with mean platelet volume and Vitamin D. Med Sci Monit. 2017;23:1378–84.PubMedPubMedCentralCrossRef
85.
Çelik G, Taş D, Tahiroğlu A, Avci A, Yüksel B, Çam P. Vitamin D deficiency in obsessive-compulsive disorder patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: a case control study. Noro Psikiyatr Ars. 2016;53(1):33–7.PubMedPubMedCentralCrossRef
86.
López-Vicente M, Sunyer J, Lertxundi N, González L, Rodríguez-Dehli C, Espada Sáenz-Torre M, et al. Maternal circulating Vitamin D(3) levels during pregnancy and behaviour across childhood. Sci Rep. 2019;9(1):14792.PubMedPubMedCentralCrossRef
87.
Bener A, Kamal M, Bener H, Bhugra D. Higher prevalence of iron deficiency as strong predictor of attention deficit hyperactivity disorder in children. Ann Med Health Sci Res. 2014;4(Suppl 3):S291–7.PubMedPubMedCentralCrossRef
88.
Wagner CL, Taylor SN, Johnson DD, Hollis BW. The role of Vitamin D in pregnancy and lactation: emerging concepts. Womens Health (Lond). 2012;8(3):323–40.PubMedCrossRef
89.
Wagner CL, Hollis BW. The Implications of Vitamin D status during pregnancy on mother and her developing child. Front Endocrinol (Lausanne). 2018;9:500.PubMedCrossRef
90.
Raymond-Lezman JR, Riskin SI. Benefits and risks of sun exposure to maintain adequate Vitamin D Levels. Cureus. 2023;15(5):e38578.PubMedPubMedCentral
91.
Palacios C, Trak-Fellermeier MA, Martinez RX, Lopez-Perez L, Lips P, Salisi JA, et al. Regimens of Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;10(10):Cd013446.PubMed
92.
Palacios C, Kostiuk LK, Peña-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;7(7):Cd008873.PubMed
93.
MacKinnon N, Kingsbury M, Mahedy L, Evans J, Colman I. The association between prenatal stress and externalizing symptoms in childhood: evidence from the avon longitudinal study of parents and children. Biol Psychiatry. 2018;83(2):100–8.PubMedCrossRef
94.
Ross AC, Manson Je Fau - Abrams SA, Abrams Sa Fau - Aloia JF, Aloia Jf Fau - Brannon PM, Brannon Pm Fau - Clinton SK, Clinton Sk Fau - Durazo-Arvizu RA, et al. The 2011 report on dietary reference intakes for calcium and Vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metabolism. 2011;96(1):53–8.
95.
Rice D, Barone S Jr. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect. 2000;108(Suppl 3):511–33.PubMedPubMedCentralCrossRef
96.
van Batenburg-Eddes T, de Groot L, Steegers EAP, Hofman A, Jaddoe VWV, Verhulst FC, Tiemeier H. Fetal programming of infant neuromotor development: the generation R study. Pediatr Res. 2010;67(2):132–7.PubMedCrossRef
97.
98.
Kazda L, Bell K, Thomas R, McGeechan K, Sims R, Barratt A. Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic scoping review. JAMA Netw Open. 2021;4(4):e215335.PubMedPubMedCentralCrossRef
99.
Russell AE, Ford T, Williams R, Russell G. The association between socioeconomic disadvantage and attention deficit/hyperactivity disorder (adhd): a systematic review. Child Psychiatry Hum Dev. 2016;47(3):440–58.PubMedCrossRef
100.
Dunn GA, Nigg JT, Sullivan EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav. 2019;182:22–34.PubMedPubMedCentralCrossRef
101.
Blum K, Chen AL, Braverman ER, Comings DE, Chen TJ, Arcuri V, et al. Attention-deficit-hyperactivity disorder and reward deficiency syndrome. Neuropsychiatr Dis Treat. 2008;4(5):893–918.PubMedPubMedCentral
102.
Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative Stress and ADHD: A Meta-Analysis. J Atten Disord. 2015;19(11):915–24.PubMedCrossRef
103.
104.
105.
106.
107.
108.
109.
Rucklidge JJ, Johnstone J, Gorman B, Boggis A, Frampton CM. Moderators of treatment response in adults with ADHD treated with a Vitamin–mineral supplement. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:163–71.PubMedCrossRef
110.
Mohammadpour N, Jazayeri S, Tehrani-Doost M, Djalali M, Hosseini M, Effatpanah M, et al. Effect of Vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: a randomized, double blind, placebo-controlled trial. (1476–8305 (Electronic)).
111.
Hemamy M, Pahlavani N, Amanollahi A, Islam SMS, McVicar J, Askari G, Malekahmadi M. The effect of Vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: a randomized controlled trial. BMC Pediatr. 2021;21(1):178.PubMedPubMedCentralCrossRef
112.
Pilz S, Trummer C, Theiler-Schwetz V, Grübler MR, Verheyen ND, Odler B, Karras SN, Zittermann A, März W. Critical Appraisal of Large Vitamin D Randomized Controlled Trials. Nutrients. 2022;14(2):303. https://​doi.​org/​10.​3390/​nu14020303.
113.
Galesanu C, Mocanu V. Vitamin d deficiency and the clinical consequences. Rev Med Chir Soc Med Nat Iasi. 2015;119(2):310–8.PubMed
114.
115.
Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498–513.PubMedPubMedCentralCrossRef
116.
Pilz S, Zittermann A, Trummer C, Theiler-Schwetz V, Lerchbaum E, Keppel MH, et al. Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect. 2019;8(2):R27-r43.PubMedPubMedCentralCrossRef
117.
Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48–54.PubMedCrossRef
118.
Xenos K, Papasavva M, Raptis A, Katsarou MS, Drakoulis N. Vitamin D supplementation and genetic polymorphisms impact on weight loss diet outcomes in caucasians: a randomized double-blind placebo-controlled clinical study. Front Med (Lausanne). 2022;9:811326.PubMedCrossRef
119.
Imani D, Razi B, Motallebnezhad M, Rezaei R. Association between Vitamin D receptor (VDR) polymorphisms and the risk of multiple sclerosis (MS): an updated meta-analysis. BMC Neurol. 2019;19(1):339.PubMedPubMedCentralCrossRef
120.
Usategui-Martín R, De Luis-Román DA, Fernández-Gómez JM, Ruiz-Mambrilla M, Pérez-Castrillón JL. Vitamin D Receptor (VDR) Gene polymorphisms modify the response to Vitamin D supplementation: a systematic review and meta-analysis. Nutrients. 2022;14(2):360. https://​doi.​org/​10.​3390/​nu14020360.
121.
Tobias DK, Luttmann-Gibson H, Mora S, Danik J, Bubes V, Copeland T, et al. Association of body weight with response to Vitamin D supplementation and metabolism. JAMA Netw Open. 2023;6(1):e2250681.PubMedPubMedCentralCrossRef
Metadaten
Titel
The Relationship Between Vitamin D and the Development and Treatment of Attention-Deficit Hyperactivity Disorder: An Overview of Systematic Reviews
verfasst von
Razi Kitaneh
Laya Jalilian-Khave
Binah Baht Ysrayl
Anna Borelli
Melissa C. Funaro
Marc N. Potenza
Gustavo A. Angarita
Publikationsdatum
10.06.2024
Verlag
Springer International Publishing
Erschienen in
Current Behavioral Neuroscience Reports / Ausgabe 3/2024
Elektronische ISSN: 2196-2979
DOI
https://doi.org/10.1007/s40473-024-00278-7

Weitere Artikel der Ausgabe 3/2024

Electroconvulsive Therapy Beyond Schizophrenia and Bipolar Disorders

Magnetic Seizure Therapy in Management of Depression: A Narrative Review

Predictors of Response to rTMS in Severe Mental Illnesses- Schizophrenia and Bipolar Disorder

A Systematic Review of Stress Physiology in Gambling Disorder and Problem Gambling

Therapeutic Innovations Against Opioid Tolerance and Addiction

Role of tDCS in Schizophrenia Management

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.

Nasenstimulation lindert chronische Migräne

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise